Bruker (BRKRP) Receivables - Other (2018 - 2026)

Bruker has reported Receivables - Other for 9 years, with the latest figure at $118.2 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other rose 21.48% year-over-year to $118.2 million; the trailing twelve-month figure through Mar 2026 stood at $118.2 million (up 21.48% YoY), and the FY2025 full-year result was $113.0 million, up 20.73% from the prior year.
• Receivables - Other for Q1 2026 stood at $118.2 million, up from $113.0 million in the prior quarter.
• The five-year high for Receivables - Other was $127.1 million in Q2 2025, with the low at $46.4 million in Q1 2022.
• Historically, Receivables - Other has averaged $89.7 million across 5 years, with a median of $92.5 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables - Other decreased 4.92% — and 2023, when it soared 49.75%.
• Bruker's Receivables - Other stood at $61.3 million in 2022, then jumped by 39.97% to $85.8 million in 2023, then increased by 9.09% to $93.6 million in 2024, then advanced by 20.73% to $113.0 million in 2025, then advanced by 4.6% to $118.2 million in 2026.
• The last three Receivables - Other figures came in at $118.2 million (Q1 2026), $113.0 million (Q4 2025), and $118.6 million (Q3 2025), per Business Quant data.